![](https://www.optiknow.ca/wp-content/uploads/2017/09/Novartis-logo-810X338px-1.jpg)
Novartis to Acquire Xiidra
Friday, May 10 2019 | 12 h 12 min | Acquisitions, News, Press Release
Novartis announced that it has entered into an agreement with Takeda Pharmaceutical Company Limited to acquire the assets associated with...
Read More![](https://www.optiknow.ca/wp-content/uploads/2018/04/Novartis_alcon-logo.jpg)
Novartis, Alcon Report Growth In Second Quarter of 2018
Tuesday, July 24 2018 | 09 h 56 min | Financial News, News
Both Novartis and Alcon reported that their net sales grew by 5%, while Alcon’s core operating income grew 14% Alcon’s net sales were USD 18...
Read More![](https://www.optiknow.ca/wp-content/uploads/2018/04/Novartis_alcon-logo.jpg)
Novartis Announces Intention to Spin Off Alcon
Friday, June 29 2018 | 11 h 33 min | News
Novartis has announced that they intend to seek shareholder approval to spin off 100% of Alcon's eye care device business into a standalone,...
Read More![](https://www.optiknow.ca/wp-content/uploads/2018/04/Novartis_alcon-logo.jpg)
Novartis Delivers Strong First Quarter in 2018
Friday, April 20 2018 | 12 h 32 min | Financial News, News, Press Release
Net sales for the first quarter of 2018 were CAD 161 billion, an increase of 4% at constant currencies Core operating income also grew by...
Read More![](https://www.optiknow.ca/wp-content/uploads/2017/09/Novartis-logo-810X338px-1.jpg)
Novartis CEO Joseph Jimenez to Retire in 2018
Wednesday, September 6 2017 | 00 h 00 min | News, Press Release
Joseph Jimenez, Chief Executive Officer (CEO) of Novartis, has informed the Board of Directors of his desire to step down as CEO in 2018, after eight...
Read More